» Articles » PMID: 38650191

One-pot Synthesis of (R)- and (S)-phenylglycinol from Bio-based L-phenylalanine by an Artificial Biocatalytic Cascade

Overview
Specialty Biochemistry
Date 2024 Apr 23
PMID 38650191
Authors
Affiliations
Soon will be listed here.
Abstract

Chiral phenylglycinol is a very important chemical in the pharmaceutical manufacturing. Current methods for synthesis of chiral phenylglycinol often suffered from unsatisfied selectivity, low product yield and using the non-renewable resourced substrates, then the synthesis of chiral phenylglycinol remain a grand challenge. Design and construction of synthetic microbial consortia is a promising strategy to convert bio-based materials into high value-added chiral compounds. In this study, we reported a six-step artificial cascade biocatalysis system for conversion of bio-based L-phenylalanine into chiral phenylglycinol. This system was designed using a microbial consortium including two engineered recombinant Escherichia coli cell modules, one recombinant E. coli cell module co-expressed six different enzymes (phenylalanine ammonia lyase/ferulic acid decarboxylase/phenylacrylic acid decarboxylase/styrene monooxygenase/epoxide hydrolase/alcohol dehydrogenase) for efficient conversion of L-phenylalanine into 2-hydroxyacetophenone. The second recombinant E. coli cell module expressed an (R)-ω-transaminase or co-expressed the (S)-ω-transaminase, alanine dehydrogenase and glucose dehydrogenase for conversion of 2-hydroxyacetophenone into (S)- or (R)-phenylglycinol, respectively. Combining the two engineered E. coli cell modules, after the optimization of bioconversion conditions (including pH, temperature, glucose concentration, amine donor concentration and cell ratio), L-phenylalanine could be easily converted into (R)-phenylglycinol and (S)-phenylglycinol with up to 99% conversion and > 99% ee. Preparative scale biotransformation was also conducted on 100-mL scale, (S)-phenylglycinol and (R)-phenylglycinol could be obtained in 71.0% and 80.5% yields, > 99% ee, and 5.19 g/L d and 4.42 g/L d productivity, respectively. The salient features of this biocatalytic cascade system are good yields, excellent ee, mild reaction condition and no need for additional cofactor (NADH/NAD), provide a practical biocatalytic method for sustainable synthesis of (S)-phenylglycinol and (R)-phenylglycinol from bio-based L-phenylalanine.

References
1.
Tan X, Zhang S, Song W, Liu J, Gao C, Chen X . A multi-enzyme cascade for efficient production of D-p-hydroxyphenylglycine from L-tyrosine. Bioresour Bioprocess. 2024; 8(1):41. PMC: 10991500. DOI: 10.1186/s40643-021-00394-2. View

2.
Becker J, Wittmann C . Systems and synthetic metabolic engineering for amino acid production - the heartbeat of industrial strain development. Curr Opin Biotechnol. 2012; 23(5):718-26. DOI: 10.1016/j.copbio.2011.12.025. View

3.
Wang F, Zhao J, Li Q, Yang J, Li R, Min J . One-pot biocatalytic route from cycloalkanes to α,ω-dicarboxylic acids by designed Escherichia coli consortia. Nat Commun. 2020; 11(1):5035. PMC: 7542165. DOI: 10.1038/s41467-020-18833-7. View

4.
Cochrane F, Davin L, Lewis N . The Arabidopsis phenylalanine ammonia lyase gene family: kinetic characterization of the four PAL isoforms. Phytochemistry. 2004; 65(11):1557-64. DOI: 10.1016/j.phytochem.2004.05.006. View

5.
Tanaka T, Kawase M, Tani S . Alpha-hydroxyketones as inhibitors of urease. Bioorg Med Chem. 2004; 12(2):501-5. DOI: 10.1016/j.bmc.2003.10.017. View